HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 23, No 09, September 2019 – Healthy Ageing — How Science is chipping in       » Officials in China make progress in development of new drugs       » The Science of Healthy Ageing       » Thailand Medtech landscape - Customer to Innovator       » China-Thailand Joint Research Institute on Medicine Launched in Bangkok      
EYE ON CHINA
AI offers breakthrough in cancer diagnosis
Takes seconds instead of minutes to examine cervical smear cells

Huawei Cloud, a subsidiary of the Chinese technology giant Huawei Technologies, and Kingmed Diagnostics, a Guangzhou-based medical diagnostic testing company, have announced a technological breakthrough in the diagnosis of cervical cancer.

By leveraging AI technologies, they can diagnose the disease with a true positive rate of over 99.9 per cent, and a true negative rate of more than 99 per cent, which is currently the highest level in the world, according to Kingmed Diagnostics.

"It takes only 36 seconds to examine cervical smear cells, which would usually need an average six minutes by cytopathologists," said Luo Pifu, director of the Kingmed Diagnostics pathological department.

Cervical cancer remains one of the biggest threats to women, with about 100,000 new cases being reported each year in China, according to Luo.

"Early examination is key to treating cervical cancer," said Luo.

However, only 70 million women have been examined since China began a nationwide examination program against cervical and breast cancers in 2009, according to Liang Xiaoman, a Guangzhou-based cytologist.

Liang said China lags in the development of pathologists, especially in rural areas.

The companies conducted research in the use of artificial technology in assisting examinations, based on 43.5 million cervical cell samples collected by Kingmed Diagnostics.

The breakthrough was also based on Huawei Cloud's Model-Arts, which provides data processing, intelligent labeling, a readily packaged development environment, automatic model generation and comprehensive AI development.

"The AI technology will help greatly increase efficiency of the diagnosis of cervical cancer, benefiting the country's 350 million women," said Liang.

According to Pan Jie, director of Huawei Cloud Guangdong business section, the AI technology may be expanded into areas of pathology such as breasts, digestion, kidneys and blood.

Source: China Daily

Click here for the complete issue.

NEWS CRUNCH  
news Philip Morris International opens artificial intelligence competition to develop improved strategies for medical diagnosis
news Kaspersky partners with Temasek Polytechnic to offer technical cybersecurity courses to more Singaporeans
news Discover the Asian nutraceuticals market at Vitafoods Asia 2019
news Singapore FinTech Festival and SWITCH come together - to bring the global innovation community to Singapore
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
SPOTLIGHT  
LIFE OF A SCIENTIST  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
February:
Marijuana as medicine — Legal marijuana will open up scientific research
March:
Driven by curiosity
April:
Career developments for researchers
May:
What's cracking — Antibodies in ostrich eggs
June:
Clinical trials — What's in a name?
July:
Traditional Chinese medicine in modern healthcare — Integrating both worlds
August:
Digitalization vs Digitization — Exploring Emerging Trends in Healthcare
September:
Healthy Ageing — How Science is chipping in
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy